Serotoninergic antidepressants and opiate analgesics: A sometimes-painful association. A case report;Antidépresseurs sérotoninergiques et antalgiques opiacés: une association parfois « douloureuse » ! propos d'un cas clinique

Encephale

Volumn 36, Issue SUPPL. 2, 2010, Pages

  Reich, M ^a   Lefebvre Kuntz, D ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

Opiate analgesics; Selective serotonin reuptake inhibitor antidepressants; Serotonin syndrome

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CYPROHEPTADINE; ESCITALOPRAM; FENTANYL; OXYCODONE; SEROTONIN 1A RECEPTOR;

AGED; ARTICLE; BLURRED VISION; BONE METASTASIS; CASE REPORT; CHRONIC PAIN; CLINICAL FEATURE; COGNITIVE DEFECT; DEPRESSION; DIAPHORESIS; DIARRHEA; DRUG WITHDRAWAL; GENERAL PRACTITIONER; HUMAN; MENTAL DISEASE; MONOTHERAPY; MOOD DISORDER; MYDRIASIS; NEUROMUSCULAR DISEASE; NIGHT SWEAT; PATHOPHYSIOLOGY; PROBABILITY; PROSTATE ADENOCARCINOMA; PSYCHIATRIST; SEROTONIN SYNDROME; SEROTONINERGIC TRANSMISSION; SIDE EFFECT; TREATMENT DURATION; TREMOR; VISUAL DISORDER; WEIGHT REDUCTION;

ADENOCARCINOMA; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; AGED; ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BONE NEOPLASMS; CITALOPRAM; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FENTANYL; HUMANS; MALE; OXYCODONE; PAIN, INTRACTABLE; PROSTATIC NEOPLASMS; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 77953022648     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2009.03.010     Document Type: Article

References (38)

1. S. Ailawadhi, K.W. Sung, and L.A. Carlson Serotonin syndrome caused by interaction between citalopram and fentanyl J Clin Pharm Ther 32 2 2007 199 202
2. T. Anderson, M. Watson, and K. Marr Le syndrome sérotoninergique: un risque latent en soins palliatifs J Eur Soins Palliat (JESP) 12 3 2005 97 100
3. E.W. Boyer, and M. Shannon The serotonin syndrome N Engl J Med 352 11 2005 112 120
4. J.R. Carbone The neuroleptic malignant and serotonin syndromes Emerg Med Clin North Am 18 2 2000 317 325
5. F.C. Colpaert, K. Deseure, and L. Stinus High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning J Pharmacol Exp Ther 316 2006 892 899
6. M. Demirkiran, J. Jankovic, and J.M. Dean Ectasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome Clin Neuropharmacol 19 2 1996 157 164
7. A.C. Egberts, J. Terborgh, and C.C. Brodie-Meijer Serotonin syndrome attributed to tramadol addition to paroxetine therapy Int Clin Psychopharmacol 12 3 1997 181 182
8. R.A. Ener, S.B. Meglathery, and W.A. Van Decker Serotonin syndrome and other serotonergic disorders Pain Med 4 1 2003 63 74
9. B. Fantino, N. Moore, and H. Verdoux Cost-effectiveness of escitalopram vs citalopram in major depressive disorder Int Clin Psychopharmacol 22 2 2007 107 115
10. P. Fischer Serotonin syndrome in the elderly after antidepressive monotherapy J Clin Psychopharmacol 15 6 1995 440 442
11. P.K. Gillman Serotonin syndrome treated with chlorpromazine J Clin Psychopharmacol 17 2 1997 128 129
12. N. Gnanadesigan, R.T. Espinoza, and R. Smith Interaction of serotoninergic antidepressants and opioid analgesics: is serotonin syndrome going undetected? J Am Med Dir Assoc 6 4 2005 265 269
13. A. Graudins, A. Stearman, and B. Chan Treatment of the serotonin syndrome with cyproheptadine J Emerg Med 16 4 1998 615 619
14. S. Hamilton, and K. Malone Serotonin syndrome during treatment with paroxetine and risperidone J Clin Psychopharmacol 20 1 2000 103 105
15. J.L. Hernandez, F.J. Ramos, and J. Infante Severe serotonin syndrome induced by mirtazapine monotherapy Ann Pharmacother 36 4 2002 641 643
16. D.J. Houlihan Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine Ann Pharmacother 38 3 2004 411 413
17. M.T. Huska, G. Catalano, and M.C. Catalano Serotonin syndrome associated with the use of escitalopram CNS Spectr 12 4 2007 270 274
18. G.K. Isbister, S.J. Bowe, and A. Dawson Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose J Toxicol Clin Toxicol 42 3 2004 277 285
19. E. Jaunay, V. Gaillac, and J.D. Guelfi Le syndrome sé rotoninergique. Quel traitement et quand? Presse Med 30 34 2001 1695 1700
20. S.D. Karki, and G.R. Masood Combinaison risperidone and SSRI-induced serotonin syndrome Ann Pharmacother 37 3 2003 388 391
21. H. Karunatilake, and N.A. Buckley Serotonin syndrome induced by fluvoxamine and oxycodone Ann Pharmacother 40 1 2006 155 157
22. S.H. Kennedy, H.F. Andersen, and R.W. Lam Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis J Psychiatry Neurosci 31 2 2006 122 131
23. P. Lheureux, A. Penaloza, and V. De Cottenier Syndrome sérotoninergique Rev Med Brux 23 5 2002 422 428
24. F. Llinares-Tello, S. Escriva-Moscardo, and F. Martinez-Pastor Possible serotoninergic syndrome associated with coadministration of paroxetine and tramadol Med Clin (Barc) 128 11 2007 438
25. F.J. Mackay, N.R. Dunn, and R.D. Mann Antidepressants and the serotonin syndrome in general practice Br J Gen Pract 49 448 1999 871 874
26. R. Mahlberg, D. Kunz, and J. Sasse Serotonin syndrome with tramadol and citalopram Am J Psychiatry 16 6 2004 1129
27. B.J. Mason, and K.H. Blackburn Possible serotonin syndrome associated with tramadol and sertraline coadministration Ann Pharmacother 31 2 1997 175 177
28. W.W. Mcdaniel Serotonin syndrome: early management with cyproheptadine Ann Pharmacother 35 7-8 2001 870 873
29. 1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner J Pharmacol Exp Ther 256 3 1991 983 992
30. D. Murdoch, and S.J. Keam Escitalopram: a review of its use in the management of major depressive disorder Drugs 65 16 2005 2379 2404
31. C.A. Naranjo, U. Busto, and E.M. Sellers A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 2 1981 239 245 (Pubitemid 12149145)
32. J.J. Pan, and W.W. Shen Serotonin syndrome induced by low-dose venlafaxine Ann Pharmacother 37 2 2003 209 211
33. J.W. Radomski, S.M. Dursun, and M.A. Reveley An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnosis criteria Med Hypotheses 55 3 2000 218 224
34. N. Rao The clinical pharmacokinetics of escitalopram Clin Pharmacokinet 46 4 2007 281 290
35. C.J. Rosebraugh, D.A. Flockhart, and S.U. Yasuda Visual hallucination and tremor induced by sertraline and oxycodone in a bone marrow transplant patient J Clin Pharmacol 41 2 2000 224 227
36. 2-adrenoceptors regulating monoamine synthesis in the brain of morphine-dependent rats Naunyn Schmiedebergs Arch Pharmacol 365 3 2002 210 219
37. S in a patient with spinal cord injury Fukushima J Med Sci 52 1 2006 29 33
38. H. Sternbach The serotonin syndrome Am J Psychiatry 148 6 1991 705 713